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Abstract: Use of thermoplastic material in orthodontics, either as aligner or as retainer appliances, is
common practice and is likely to increase in the years to come. However, no systematic assessment on
safety considerations of these adjuncts has been implemented up to date. The aim of this systematic
review was to collectively appraise the existing evidence from both clinical and laboratory studies, on
whether these appliances are associated with any estrogenic/cytotoxic effects or bisphenol-A (BPA) and
monomer leaching. Eight electronic databases were searched with no limits in December 22, 2019, for
published and unpublished research. Eligibility criteria comprised of studies of any design, describing
use of any type of thermoplastic aligner. Study selection, data extraction and risk of bias (RoB) assess-
ment was done independently, either in duplicate or confirmed by a second reviewer. Random effects
meta-analyses of weighted mean differences (WMD) with associated 95% Confidence Intervals (CIs) were
planned. Quality of the evidence was evaluated with Grading of Recommendations Assessment, Develop-
ment and Evaluation (GRADE). A total of 58 articles were initially identified, while 5 were included in
qualitative synthesis and 2 of those contributed to the quantitative syntheses. Four studies were in-vitro,
while one was a randomized controlled trial; all assessed some type of orthodontic aligner or retainer,
either as-received or retrieved. Risk of bias recordings ranged between unclear and high for all studies.
Proliferation induction capacity of thermoplastic appliances’ eluents on MCF-7 cells failed to be con-
firmed compared to beta-estradiol (2 studies: 5% v/v, WMD: -182.08; 95% CI: -198.83, -165.33; p-value
< 0.001; and 20% v/v, WMD: -184.53; 95% CI: -206.17, -162.88; p-value < 0.001). No cytotoxic activity
was detected as well. In addition, although evidence from in-vitro studies was indicative of no traceable
detection of BPA or other monomers, the findings from a single clinical trial were allied to increased
levels of BPA in whole stimulated saliva, after up to 30 days of thermoplastic retainer usage, compared
to standard Hawley retainer. The quality of the evidence overall was low to medium. Current data from
in-vitro research are indicative of an absence of an estrogenic or cytotoxic effect of thermoplastic aligners
or retainers. Regarding BPA or monomer release, evidence from clinical and laboratory studies appear
inconsistent.
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Abstract: Use of thermoplastic material in orthodontics, either as aligner or as retainer appliances, is
common practice and is likely to increase in the years to come. However, no systematic assessment on
safety considerations of these adjuncts has been implemented up to date. The aim of this systematic
review was to collectively appraise the existing evidence from both clinical and laboratory studies,
on whether these appliances are associated with any estrogenic/cytotoxic effects or bisphenol-A
(BPA) and monomer leaching. Eight electronic databases were searched with no limits in December
22, 2019, for published and unpublished research. Eligibility criteria comprised of studies of any
design, describing use of any type of thermoplastic aligner. Study selection, data extraction and
risk of bias (RoB) assessment was done independently, either in duplicate or confirmed by a second
reviewer. Random effects meta-analyses of weighted mean differences (WMD) with associated 95%
Confidence Intervals (CIs) were planned. Quality of the evidence was evaluated with Grading of
Recommendations Assessment, Development and Evaluation (GRADE). A total of 58 articles were
initially identified, while 5 were included in qualitative synthesis and 2 of those contributed to the
quantitative syntheses. Four studies were in-vitro, while one was a randomized controlled trial;
all assessed some type of orthodontic aligner or retainer, either as-received or retrieved. Risk of
bias recordings ranged between unclear and high for all studies. Proliferation induction capacity of
thermoplastic appliances’ eluents on MCF-7 cells failed to be confirmed compared to beta-estradiol
(2 studies: 5% v/v, WMD: −182.08; 95% CI: −198.83, −165.33; p-value < 0.001; and 20% v/v, WMD:
−184.53; 95% CI: −206.17, −162.88; p-value < 0.001). No cytotoxic activity was detected as well. In
addition, although evidence from in-vitro studies was indicative of no traceable detection of BPA
or other monomers, the findings from a single clinical trial were allied to increased levels of BPA in
whole stimulated saliva, after up to 30 days of thermoplastic retainer usage, compared to standard
Hawley retainer. The quality of the evidence overall was low to medium. Current data from in-vitro
research are indicative of an absence of an estrogenic or cytotoxic effect of thermoplastic aligners
or retainers. Regarding BPA or monomer release, evidence from clinical and laboratory studies
appear inconsistent.
Keywords: orthodontic aligner; orthodontic retainer; clear aligner; thermoplastic; vacuum-formed;
bisphenol-A; BPA; cytotoxicity; estrogenicity; systematic review
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1. Introduction
Aligner orthodontic therapy has been in the spotlight of the recent years, partially due to potentially
aggressive promotion policies of companies, manufacturers and stakeholders but also due to patients’
perception for ‘invisible’ orthodontics and aesthetic considerations. It is noteworthy that the increase
in the use of aligners as the sole means or adjunct for tooth movement and full orthodontic treatment
has reached considerable amounts [1]. The reported increase in the use of aligners by orthodontists
in the United States within a period of 6 to 7 years has reached 15%, while the number of patients
receiving treatment with aligners has been nearly duplicated [2].
As a rather “new” adjunct for the orthodontist but with upcoming massive use, aligner treatment
should be subject to assessment in terms of its efficacy and safety for clinical operation. The latest
meta-analysis report on the efficacy of aligners compared to the gold standard of fixed appliances,
allowing for individual study caveats, revealed that aligner treatment cannot be considered equally
effective to braces at present, while their use is associated with worse treatment outcome [3,4].
However, with regard to safety considerations on the use of aligners, no similar comprehensive effort
has been attempted. Sporadic reports, mainly in vitro, have examined potential cytotoxic effects of
these appliances [5,6]. Recently, an in-vivo study on retainers has documented increased levels of
bisphenol-A (BPA) release in saliva of patients using vacuum-formed thermoplastic adjuncts during the
retention phase, compared to the use of classic Hawley-type appliances [7]. Thermoplastic orthodontic
adjuncts as retainers cannot be considered inferior to the classic type-Hawley retainers at present and
in view of the available evidence on certain perspectives, such as stability or attainment of proper oral
hygiene [8]. Moreover, they have also been associated with increased patients’ compliance [9].
Bisphenol-A constitutes a well-established monomer used during the production of a wide
variety of orthodontic materials, for manufacturing of a range of polymers, such as resin composites,
esthetic brackets, elastomeric ligatures but also thermoplastic aligner or retainer systems. It is a raw
chemical used as a precursor of bisphenol A-glycidyl methacrylate (Bis-GMA) during its manufacturing
phase [10]. Concerns regarding BPA release from clinically usable materials have been oriented towards
identifying on one part whether these orthodontic materials bear the potential to exhibit estrogenic or
other cytotoxic actions; on the other hand, towards detecting bisphenol-A release or residual monomer
leaching [5,10–12].
Therefore, the aim of the present systematic review was to comprehensively collect and appraise the
existing evidence from either in-vitro or clinical research, if the latest exists, as to whether thermoplastic
aligner or retainer use in orthodontics has been associated with increased levels of BPA release or
residual monomer leaching and also to record any profound cytotoxic or estrogenic effects. The null
hypothesis was that aligners/retainers cannot be linked to any of the above-mentioned activities.
2. Materials and Methods
2.1. Protocol Registration and Reporting
The protocol of this study has been registered in the Open Science Framework as of January 20,
2020 (https://osf.io/9wsy2/) [13]. Reporting has been conducted in line with the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [14,15].
2.2. Eligibility Criteria
Eligibility criteria for study selection have been schemed as follows:
1. Study design: any type of study, irrespective of the design, that is, randomized controlled trial,
prospective clinical trial, retrospective cohort, in-vitro, pre-clinical studies, irrespective of the
groups under comparison.
2. Participants: patients undergoing orthodontic treatment with aligners or wearing retainers
after the fulfillment of orthodontic treatment are considered eligible for clinical studies. For
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in-vitro/pre-clinical research, any type of thermoplastic aligner either retrieved or as-received
was included.
3. Intervention: any type of thermoplastic aligner/retainer (retrieved/as-received) used in
clinical or in-vitro research. These include all types or material thickness, type, activation
with/without attachments.
4. Comparator: any type of thermoplastic aligner/retainer used as comparator group or even studies
without a comparator/control group involved.
5. Outcome: BPA-release, any type of monomer release including BisGMA, triethylene glycol
dimethacrylate (TEGDMA) and byproducts. Also, outcomes indicating cell proliferation activity,
including but not confined to MCF-7 breast cancer cells or other estrogen-responsive cells.
6. Exclusion criteria: case studies, studies involving raw thermoplastic materials/sheets used for
aligners/retainers but not pressed and formed as aligners/retainers for clinical use.
2.3. Search Strategy
Electronic searching was conducted within 8 databases including published and unpublished
research, with no language/date restriction or other filter modifications (Appendix A). The date of
search within all databases was December 22, 2019. The respective databases were—Medline via
PubMed, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database
of Systematic Reviews (CDSR) and Google Scholar. Moreover, unpublished literature was searched
in the Open Grey, the ClinicalTrials.gov (www.clinicaltrials.gov), the National Research Register
(www.controlled-trials.com). Hand searching of the eligible for inclusion articles was employed for any
additional potential inclusion and authors of the included papers were contacted when in need to clarify
on data extraction or data curation. Keywords involved “thermoplastic aligner,” “vacuum-formed
retainer,” “bisphenol-A release,” “BPA release,” “monomer release,” “estrogenicity.”
Titles and abstracts of papers were extracted first, followed by full text assessment. Eligibility
assessment was performed independently and in duplicate by two authors (A.I., D.K.), while any
disagreements were settled through discussion and a consensus was reached with the involvement of
a third reviewer (T.E.).
2.4. Data Extraction
Data extraction was employed in pre-piloted standardized forms by a single reviewer (A.I.), not
blinded to study origin or author identity, while all entries were confirmed by a second investigator
(D.K.). Specifically, information entries were related to study identity, study design, sample size,
intervention, comparators, outcomes, method of analysis.
2.5. Risk of Bias Assessment within Individual Studies
Risk of bias assessment was performed independently and in duplicate by two authors (A.I.,
D.K.). Any disagreements were settled after consultation with a third author (T.E.). For the potentially
included randomized controlled trials, the updated Cochrane RoB 2.0 tool was planned to be used [16]
(Sterne 2019). A modification of this tool was utilized for the included in-vitro/pre-clinical studies,
as no pre-determined guidelines to assess the risk of bias exist and in order to incorporate specific
important elements that would help identify the presence of potential bias. These include selection
bias [17,18], performance bias [19], attrition bias [20] and reporting issues [21,22].
2.6. Summary Measures and Data Synthesis
Prior to any decision to quantitatively pool together data from individual studies, clinical
heterogeneity was examined in terms of individual study settings, trial or laboratory conditions,
inclusion criteria or methods of analyses. If possible, statistical heterogeneity was planned to be
examined, first visually, through inspection of the confidence bounds within the forest plots, as well
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as statistically, as indicated by a p-value below the level of 10% for the test (p < 0.10) [23]. I2 test for
homogeneity was also planned to be undertaken.
Random-effects meta-analyses were planned as they were considered more appropriate to
incorporate individual study findings if possible. In view of the anticipated continuous nature of
the expected outcomes, treatment effects were planned to be calculated through pooled weighted
mean differences (WMD) or mean differences (MD) for single studies with associated 95% Confidence
Intervals (95% CIs).
2.7. Risk of Bias across Studies
If more than 10 studies were included in meta-analyses, publication bias was to be explored
through standard funnel plots [24] and Egger’s regression test [25].
2.8. Assessment of the Quality of the Evidence
The Grading of Recommendations Assessment, Development and Evaluation (GRADE) were
implemented to assess the overall quality of evidence as formulated by the interventions and the
outcomes under evaluation [26,27]. According to GRADE the overall body of evidence is rated as high,
moderate, low and very low. The ratings, with regard to the likelihood for a change in our confidence
in the estimated effect, range from very unlikely to very likely. In addition, when the overall quality of
the body of evidence is very low, then any estimated effect is particularly uncertain. Assessment of the
body of evidence and the initial starting-up level depends on the study design. In terms of randomized
designs, which present a theoretically ‘high’ quality of the evidence, assessment is made following
the domains: risk of bias, inconsistency, indirectness, imprecision and publication bias. For the first 4
domains the quality of evidence may be downgraded on the basis of either ‘serious’ or ‘very serious’
risks (1 or 2 levels respectively); publication bias may either be suspected or undetected (2 levels). For
non-randomized/observational designs, which theoretically start from a ‘low’ level of evidence, there
are 3 perspectives for upgrade: a large effect, a plausible residual confounding that may alter the effect
or a dose-response gradient. The level of evidence may be upgraded by 1 or 2 levels (large effect) or 1
level (plausible confounding, does-response gradient).
All analyses were undertaken in Stata version 15.1 software (StataCorp, College Station, TX, USA).
3. Results
3.1. Search Details
A total number of 58 results were initially retrieved after application of electronic search strategies.
After duplicate exclusion and screening first by title and subsequently by abstract, eleven articles were
left for full-text assessment, leaving 5 to be included in the qualitative synthesis [5–7,28,29]. Of these, 2
contributed to meta-analyses for different outcomes [5,6] (Figure 1).
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Figure 1. Flow diagram of study selection.
3.2. Study Design and Characteristics
Detailed information about study design and characteristics is presented in Table 1.
Studies presented a variable origin background, with authorship affiliation to Europe, Asia, the
United States as well as the United Arab Emirates. The first study in the field dates back to 2004 [29],
while in the last five years only two research papers described the results of safety considerations
regarding thermoplastic appliances used for orthodontic purposes either in the course of treatment or
in the retention phase [6,7].
Only one study presented a clinical trial design (randomized controlled trial, RCT) [7], while the
remaining 4 examined outcomes on in-vitro tested materials in the laboratory [5,6,28,29]. Three studies
tested on both as-received (or-pretreatment) and retrieved (after use) material [6,7,29], while 2 only on
newly received aligners [5,28]. Sample sizes for aligner units ranged from 6 to 45, while when aligners’
eluents were examined for cell response or monomer/BPA leaching, the respective contributing units
were effectively larger, constituting up to 96 eluent samples from respective micro-wells examined.
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Table 1. Data extraction information for included studies (origin, study design, sample size, technical analysis methodology, comparisons and outcomes).





n = 12 Vivera® retainers,
6 for each of the two
groups (48 aligner eluents
per group)
Estrogenicity assays, two line cells (MCF-7,
MDA-MB-231). Cells cultured in Dulbecco’s
modified eagle medium (DMEM)
supplemented with 10% fetal bovine serum,
at 37 ◦C, in 5% carbon dioxide. Finally, the
cells were detached using trypsin-citrate
solution and counted in a Z1
Beckman-Coulter counter. (48-well,
flat-bottomed microwells, with
approximately 10,000 cells per well),
received samples of aligner solution eluents
1. New (as-received) (n = 6) vs 2. Retrieved
after 4w of use (12 h/day) (n = 6) (overall
breakdown: Non sterilized (n = 2), Sterilized
through gamma-irradiation (n = 5),
Sterilized through autoclaving (n = 5));
b-Estradiol (β-E2) was used as positive
control; Solutions, at concentrations: 5%,
10% and 20%
1. estrogenicity assessed by cell
counting/proliferation (MCF-7,
MDA-MB-231); note: no estrogenic





3 sets of aligners
(Invisalign, Align tech®)
n = 6 (3 maxillay, 3
mandibular) (96 aligner
eluents per group)
Cytotoxicity: by a modification of the MTT
(Sigma, St Louis, Mo) assay; Estrogenicity:
assays involved 2 cell lines: MCF-7 and
MDA-MB-231. (96-well, flat-bottomed
microwells, with approximately 5000 cells
per well), received samples of aligner
solution eluents
Eluents were diluted to 5%, 10% and 20%
vol/vol, normal saline solution served as
negative control and b-estradiol (β-E2) and
BPA was used as positive controls
1. cytotoxicity (optical density of
human gingival fibroblasts); 2.
estrogenicity assessed by
proliferation of MCF-7 and





8 retainer materials, cut
into pieces of unspecified
number
GC-MS
1. Prethermoformed Biocryl Essix
2. Thermoformed Biocryl Essix
3. Prethermoformed Biocryl Retainer
4. Thermoformed Biocryl Retainer
5. Prethermoformed Dentsply Raintree Essix
6. Thermoformed Dentsply Essix
7. Unused Invisalign aligner
8. Used Invisalign aligner
1. BPA concentration (ppm/gr); note:
leached concentrations and masses of
BPA only for Thermoformed Biocryl




India (RCT) n = 45 HPLC
1. Vacuum-formed retainer, n = 15;
2. Hawley (heat cure), n = 15;
3. Hawley retainer (chemical cure), n = 15; at
4 time points: T0 (before placement), T1 (1
hour), T2 (1 week), T3 (1 month)
1. BPA levels of simulated whole
saliva; note: highest levels were






n = 10 samples of aligners
(Invisalign, Align tech)
before intraoral placement
(as received) and after
retrieval; n = 12 samples
of same aligners after
placement intraorally for
22 h, for 2 weeks
Reflection microscopy, FTIR, scanning
electron microscopy, vickers hardness,
GC-MS
1. before placement, n = 10; 2. after retrieval
(2 weeks), n = 12
1. aligner morphological variation
(reflection microscopy, FTIR,
scanning electron microscopy, vickers
hardness); 2. substance leaching
(GC-MS); note: no residual
monomers or oxidative byproducts
detected
RCT, randomized controlled trial; β-E2, beta estradiol; BPA, bisphenol-A; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; GS-MS, gas chromatography–mass
spectrometry; HPLC, high-performance liquid chromatography; FTIR, Fourier transform infrared spectroscopy.
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Two studies searched for the potentially estrogenic effect of aligners’ eluents linked to their
capacity to induce proliferation of breast cancer cells (MCF-7), using either beta-estradiol [5,6] or
BPA [5] as a positive control for comparison. The latter report [5] also searched for the potential of
eluents of aligners to produce proliferative activity of human gingival fibroblasts, thus indicating a
cytotoxic dynamic. All immersion media concentration used, had a range between 5% vol/vol and 20%
vol/vol. The study of Schuster 2004 [29] focused on broader outcomes of structural conformation of the
material as well as on in-vitro substance leaching. BPA leaching was also the reported outcome for the
study of Kotyk 2014 [28], which reported on a wide range of dental materials including thermoplastic
retainers. The primary outcome of the sole clinical trial included in this review was whole stimulated
saliva BPA levels after the use of three-types of retainers including a thermoplastic vacuum formed
one, after a consecutive time-points of 1 day, 7 days and 30 days of aligner use [7].
Technical analysis methodology of the included studies pertained to a spectrum of tools, in close
proximity with the reported outcome. These included, estrogenicity and/or cytotoxicity assays for cell
culture [5,6], gas chromatography–mass spectrometry (GS-MS) [28,29] and high-performance liquid
chromatography (HPLC) [7].
3.3. Risk of Bias within Studies
Internal validity of the included studies ranged from unclear to high risk of bias for the in-vitro




Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each
included study. The green plus sign indicates low risk of bias; the yellow question-mark, unclear and
the red minus, high.
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Breakdown to specific risk of bias tool domains for the in-vitro studies, revealed as the most
afflicted domain, the potential lack of blinding of the outcome assessors, directly linked to detection
bias, with no information provided in any of the four in-vitro design studies. In addition, no data
implied the existence of a pre-registered protocol of the study, thus raising concerns about selective
reporting overall. Contrary, baseline similarity of the experimental groups was considered adequate
for all studies, while retaining of the materials throughout the experiment was also reasonable. For
the RCT [7], the weakest domains pertained to randomization issues not adequately reported and
possibly conducted, as well as concerns related to participants’ or investigators’ awareness of the
intervention that might have potentially led to non-compliance or deviations from the intended
intervention. Some concerns were also raised for the possibility of this study being prone to detection
bias or selective reporting.
3.4. Effects of Interventions, Meta-Analyses and Additional Analyses
Overall, two articles contributed to meta-analyses, while there was a range of outcomes recorded
across the included studies. Quantitative data from mathematical syntheses, as well as from individual
single study findings are shown in Table 3.
Proliferation induction capacity of aligners’ (retainers’) eluents on MCF-7 cells failed to be
confirmed for any of the upper or lower extreme immersion media concentrations (5% vol/vol and
20% vol/vol), that were used in the laboratory studies. They presented a significantly lower cancer cell
proliferation dynamic, as expressed by the percentage of the control vehicle used in vitro, compared to
beta-estradiol (5% v/v, WMD: −182.08; 95% CI: −198.83, −165.33; p-value < 0.001; Figure 3 and 20%
v/v, WMD: −184.53; 95% CI: −206.17, −162.88; p-value < 0.001; Figure 4). In essence, the proliferative
activity of the appliances’ eluents were in the same levels or even lower of those recorded for the
control normal saline vehicle, while this was not the case for beta-estradiol (Table 3).
 
 
− − − −
− −
Figure 3. Random effects meta-analysis on the effect of thermoplastic appliances’ eluents versus
beta-estradiol (5% v/v) to induce proliferation activity of MCF-7 cells.
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Table 3. Quantitative data from meta-analyses and individual single studies for related groups under comparison and outcomes. The minus sign (-) shows lower effect
for the first reported group. Bold indicate statistically significant comparisons.
# Study ID









(Al Naqbi 2018) Aligner eluents (48, 96.0,
3.5) vs E2 (48, 286.4, 22.8) (Eliades 2009)
Aligner eluents (96, 85.6, 17.4) vs E2 (96,
258.9, 38.9)
MCF-7 proliferation (5% v/v), %






(Al Naqbi 2018) Aligner eluents (48,
101.5, 2.14) vs E2 (48, 296.7, 10.8) (Eliades
2009) Aligner eluents (96, 85.8, 17.9) vs
E2 (96, 258.9, 38.9)
MCF-7 proliferation (20% v/v), %






1 study (Eliades 2009)
[5]
Aligner Eluents (96, 85.6, 17.4) BPA (96,
159.7, 15.8)
MCF-7 proliferation (5% v/v), %





Aligner Eluents (96, 85.8, 17.9)
BPA (96, 159.7, 15.8)
MCF-7 proliferation (20% v/v), %







VFR (15, 2.38, 1.80)
Hheat (15, 3.9 × 10−4, 0.89 × 10−5)





VFR (15, 2.38, 1.80)
Hchem (15, 3.54 × 10−3, 0.50 × 10−3)





Hheat (15, 3.9 × 10−4, 0.89 × 10−5)
Hchem (15, 3.5 × 10−3, 0.50 × 10−3)






VFR (15, 0.20, 0.09)
Hheat (15, 6.1 × 10−4, 14 × 10−4)





VFR (15, 0.20, 0.09)
Hchem (15, 9.25 × 10−3, 2.4 × 10−3)





Hheat (15, 6.1 × 10−4, 14 × 10−4)
Hchem (15, 9.25 × 10−3, 2.4 × 10−3)




N, number of patients/sample eluents; WMD, weighted mean difference; MD, mean difference; SD, standard deviation; E2, beta-estradiol; BPA, bisphenol-A; VFR, vacuum-formed retainer;
Hheat, Hawley heat-cured; Hchem, Hawley chemically-cured.
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Figure 4. Random effects meta-analysis on the effect of thermoplastic appliances’ eluents versus
beta-estradiol (20% v/v) to induce proliferation activity of MCF-7 cells.
Similarly, the results of a single study [5] that used BPA as an active control compared to aligners’
eluents MCF-7 cell proliferation dynamics, were in the same line as with beta-estradiol described
above (5% v/v, MD: −74.1; 95% CI: −78.8, −69.4; p-value < 0.001 and 20% v/v, MD: −73.9; 95% CI: −78.7,
−69.1; p-value < 0.001) (Table 3). Cytotoxic activity based on the potential for proliferation of human
gingival fibroblasts, as reported in the same single study, was also not detected for aligners’ eluents
and appeared even lower that the control normal saline. The single studies of Kotyk 2014 [28] and
Schuster 2004 [29], did not report any measurable traces of either BPA or residual monomers and
oxidative byproducts for any thermoplastic aligner/retainer under study.
With regard to the single RCT included [7], there was evidence that vacuum-formed retainers were
associated with increased levels of BPA in whole stimulated saliva, within a period of 30 days evaluation
(Table 3). Specifically, after 7 days of retainer wear, BPA levels (in ppm) in saliva were significantly
higher for vacuum-formed retainers compared to both heat-cured common type Hawley appliances
(MD: 2.38; 95% CI: 1.47, 3.29; p-value < 0.001), as well as chemically-cured Hawley retainers (MD: 2.38;
95% CI: 1.47, 3.29; p-value < 0.001). Following, there was a downstream reduction of the effect after
30 days of patients’ use but still remained significantly higher in those allocated to vacuum-formed
versus heat-cured (MD: 0.20; 95% CI: 0.16, 0.25; p-value < 0.001), as well as chemically-cured Hawley
retainers (MD: 0.20; 95% CI: 0.15, 0.24; p-value < 0.001).
3.5. Risk of Bias across Studies
Publication bias and small-study effects could not be explored, in view of the limited number of
studies included.
3.6. Quality of the Evidence
The assessment of the quality of the evidence for estrogenicity related issues and induction of
cancer cell proliferation in-vitro, revealed that the quality of the evidence was moderate. Justification
of specific grading is presented in Table 4. Most importantly the level of evidence was downgraded
due to heterogeneity related factors, while it was upgraded due to an observed large pooled estimated
effect. In addition, the quality of the evidence was rated as low for BPA and cancer cell proliferation
in-vitro. Further downgrading was implemented due to the assumed imprecision of the estimated
effect, as only one study actually contributed (Table 4).
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Table 4. Summary of Findings Table and quality of the evidence regarding aligners’ eluents capacity to induce MCF-7 cell proliferation.
Aligners’ Eluents Compared to Beta-Estradiol/BPA for Estrogenicity and BPA Leaching (through Induction of MCF-7 Proliferation)
Sample Population (Eluents): For Assessment of Estrogenicity and BPA Leaching
Settings: In-Vitro Design
Intervention: Aligners’ Eluents
Comparison: Beta-Estradiol (E2)/or Bisphenol-A (BPA), as Positive Control
Outcomes
Illustrative Comparative Risks * (95% CI)
No of Samples
(Eluents) (Studies)
Quality of the Evidence
(GRADE)
Assumed Risk Corresponding Risk − −
− Beta-Estradiol/BPA Aligners’ Eluents − −
MCF-7 cell proliferation (5%
v/v), % of control vehicle/E2
−
The mean MCF-7 cell proliferation (5% v/v), as
% of control vehicle in the intervention groups
was 182.1 lower (198.8 lower to 165.3 higher)
288 (2 studies) ⊕⊕⊕⊖moderate 1,2,3
MCF-7 cell proliferation (20%
v/v), % of control vehicle/E2
−
The mean MCF-7 cell proliferation (20% v/v), as
% of control vehicle in the intervention groups
was 184.5 lower (206.2 to 162.9 lower)
288 (2 studies) ⊕⊕⊕⊖moderate 1,2,3
MCF-7 proliferation (5% v/v), %
of control vehicle/BPA
−
The mean MCF-7 proliferation (5% v/v), as % of
control vehicle in the intervention groups was
74.1 lower (78.8 to 69.4 lower)
192 (1 study) ⊕⊕⊖⊖ low 4,5,6
MCF-7 cell proliferation (20%
v/v), % of control vehicle/BPA
−
The mean MCF-7 cell proliferation (20% v/v), as
% of control vehicle in the intervention groups
was 73.9 lower (78.7 to 69.1 lower)
192 (1 study) ⊕⊕⊖⊖ low 4,5,6
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; E2: beta-estradiol; BPA: bisphenol-A; MCF-7:breast cancer cells.
1 despite unclear risk of bias for certain domains in both studies, it was decided not to downgrade the quality of evidence for this reason. 2 downgraded 1 level for serious heterogeneity.
3 upgraded 2 levels for very large effect size. 4 despite unclear risk of bias for certain domains, it was decided not to downgrade the quality of evidence for this reason. 5 downgraded 1
level for imprecision, as only one study was included. 6 upgraded 1 level for large effect size.
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Regarding the BPA levels of different types of retainers after clinical use for up to 30 days, the
quality of the evidence was graded as low, mainly due to serious shortcomings related to methodological
limitations or risk of bias in certain domains of the included RCT (Table S2).
4. Discussion
4.1. Summary of the Evidence
In view of the increasing use of thermoplastic aligners either as orthodontic treatment adjuncts
for “invisible” orthodontics or as passive appliances used at the retention phase, this systematic review
comes timely for a comprehensive assessment on safety considerations after quite a few years of
clinical use. As evidence from in-vitro studies seems to accrue, albeit within a limited speed rate,
data from clinical trials on safety of thermoplastic appliances used for orthodontic-related reasons,
currently lags behind; Notwithstanding this, physical and mechanical properties of thermoplastic
adjuncts prior to or after intraoral service, have gained a considerably higher amount of interest in the
scientific community, allied with their clinical use, with material conformation and thermoforming
effect being the most eminent prognostic factors for the appliances’ properties’ variability [30,31]. On
safety grounds, with regard to BPA leaching, only one high risk of bias and low quality of the evidence
trial has been published up to date.
Concerns on BPA release from everyday consumption products and the effects on human organs
dates back to 1980s or 1990s, when researchers documented suspicious for estrogenic activity doses
close but even lower than the nationally set of baseline dose of 50µg per weight, by the United
States (US) Environmental Protection Agency (EPA) [32]. In essence, animal and in-vitro studies had
underpinned the effect of the monomer on tissues and cells, on par with 17-beta estradiol, a natural
estrogen. As such, bisphenol-A has been reported to act through mimicking the natural estrogen and to
allow for a number of estrogenic or cytotoxic effects to take place within live organisms. Some of these
effects include insulin tolerance through the disruption of beta-pancreatic cells’ physiologic activity [33],
disruption of physiologic prostate development or increased risk for prostate cancer in men and breast
cancer in women [34,35] or alterations in the physiology of mammary gland development [36].
Although a number of studies have raised early concerns about BPA release or monomer
leaching related not only to dental adhesives/resins [37,38] but also to orthodontic materials in
use [29,39,40], evidence on safety considerations of thermoplastic aligners or retainer adjuncts is not
that straightforward and abundant.
Findings from the laboratory studies seem to agree that there is no discernable cancer cell
proliferation inducing capacity of thermoplastic orthodontic adjuncts, either of as-received (new) [5,6]
or of patient retrieved [6]. Effectively this was the case, when tested against the standard estradiol
dynamics for cell proliferation or even for the BPA effects on such cells. However, when retrieved
retainers were examined, they had been previously undergone some kind of sterilization procedure
which might have masked a potentially altered effect on the dynamics for cell proliferation. Nevertheless,
such an effect of a sterilization procedure was not evident for as-received appliances. On the other side,
findings from the sole RCT on the topic [7], revealed a clearly documented effect of vacuum-formed
retainers over standard Hawley appliances, on the promotion of BPA leaching, primarily in short
term after usage but also within the limit of 1 month, that was actually the longest follow-up period
examined. Interestingly, such an association had not been detected by two earlier in-vitro studies
on the topic [28,29], which did not report anything on detection of BPA or leaching of other residual
monomers or oxidative byproducts, at least at a considerable amount.
4.2. Findings in Context
A critical step towards interpretation of the existing level of evidence and its placement in the
appropriate context would be to acknowledge the potentially different picture of a thermoplastic
appliance’s behavior within the oral cavity and under strict experimental conditions [10]. Clinical
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use of orthodontic aligners or retainers is subject to unavoidable and unpredictable mastication
stress, variations in oral cavity pH and/or temperature, which, allied with the patients’ cooperation
in appliances’ wear, may form a variable entirety that may not be captured by laboratory conditions
and instrumental assessment. A recent study on the surface roughness and mechanical properties of
commercially available aligners after short term clinical use has revealed significant material properties’
differences compared to non-aged material, as well as appliance wear even after only one week of
service [41]. It may be speculated that this is mostly important for aligner-type adjuncts that may
actively impose certain amounts of stress levels to induce a desirable tooth movement. On the other
hand, passive vacuum-formed thermoplastic retainers may not be subject to increased levels of intraoral
stress and one might argue against the high potential of intraoral wear, thus afflicting with safety
considerations on monomer leaching intraorally; notwithstanding, the duration of a retainer wear
may probably be by far more elongated that that of an aligner, allowing a non-negligible amount of
intraoral mastication forces and dentition-retainer interaction to take place, especially if one considers
the occlusal contacts.
On top of that, the inclusion of resin-based attachments to aligner therapy in an attempt to guide
tooth movement and orchestrate tooth displacement more effectively, has become almost universal
among the users of such treatment alternatives [42,43]. Apparently, the inclusion of such auxiliaries to
a full-case orthodontic treatment with aligners gives rise to certain emerging issues: first, the inclusion
of additional adhesive/resin based materials, of variable number, size and scheme or shape, which
present themselves as “extensions” to natural dentition bounds, are possibly likely to demonstrate
estrogenic activity through BPA/monomer release in the oral cavity. This may be employed both
through intraoral aging of the material but also through production of aerosol compounds at the
removal stage at the end of the aligner treatment [44,45]. Aerosol creation and simultaneous inhalation
has been regarded detrimental, if deposited to the respiratory system [46]. Second, attachment-aligner
interface is likely to create constant abrasion of attachment materials following multiple rounds of
placement and removal of the aligners, even within a single day of service. Such practices are most
probably likely to create material particles released within the oral environment. In the light of the
aforementioned considerations, any further inference on the potentially estrogenic or cytotoxic effects
of contemporary treatment with aligners may only be speculative, at present. Further research in the
field is more than crucial.
4.3. Strengths and Limitations
Although we allowed for a wide variety of types of study designs to satisfy eligibility criteria,
the final number of included studies was limited in view of the paucity of related research; however
this reflects the identity and level of existing evidence up to date. Methodological limitations of the
included studies are certainly not to be neglected and any individual study interpretation or summary
conclusion should be considered under the prism of the identified shortcomings.
Our study protocol was openly registered a priori, search strategy involved eight databases
including unpublished theses/studies identified within registries, while the conduct and reporting of
the review followed well-stablished guidelines [14,15] and included a formal assessment of the quality
of the evidence (GRADE) [26,27]. It was also straightforward that the existing research studies were
confined almost uniquely to in-vitro research projects that aimed to assess the BPA leaching and the
potential for simulation of cancer cell proliferation, following estrogenic and cytotoxic actions.
5. Conclusions
Overall, no estrogenic or cytotoxic effect of the thermoplastic appliances could be confirmed based
on limited preliminary evidence from in-vitro studies, while their effect on monomer or BPA release
across both in-vitro and clinical evidence remains ambiguous. As the current picture of data and
available evidence remains obscure and often inconsistent, the most promising approach would be
to welcome new laboratory studies and most importantly new clinical trials, to the highest level of
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conduct and reporting. This would allow for solid and robust inferences for clinical decision making,
which we are currently missing.
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Appendix A
Table A1. Search strategy for study selection across databases.




((essix) OR (vacuum formed aligner) OR (vacuum-formed aligner) OR (thermoplastic aligner) OR
(aligner) OR (clear aligner) OR (invisalign) OR (vacuum-formed retainer) OR (vacuum formed
retainer)) AND ((BPA) OR (BPA release) OR (bisphenol A) OR (bisphenol-A) OR (bisphenol-A release)




((essix) OR (vacuum formed aligner) OR (vacuum-formed aligner) OR (thermoplastic aligner) OR
(aligner) OR (clear aligner) OR (invisalign) OR (vacuum-formed retainer) OR (vacuum formed
retainer)) AND ((BPA) OR (BPA release) OR (bisphenol A) OR (bisphenol-A) OR (bisphenol-A release)
OR (bisphenol A release) OR (monomer) OR (monomer release) OR (cytotoxicity) OR (estrogenicity))
3.
Cochrane Central Register of Controlled Trials (CENTRAL)
15
((essix) OR (vacuum formed aligner) OR (vacuum-formed aligner) OR (thermoplastic aligner) OR
(aligner) OR (clear aligner) OR (invisalign) OR (vacuum-formed retainer) OR (vacuum formed
retainer)) AND ((BPA) OR (BPA release) OR (bisphenol A) OR (bisphenol-A) OR (bisphenol-A release)
OR (bisphenol A release) OR (monomer) OR (monomer release) OR (cytotoxicity) OR (estrogenicity))
4.
Cochrane Database of Systematic Reviews (CDSR)
0
((essix) OR (vacuum formed aligner) OR (vacuum-formed aligner) OR (thermoplastic aligner) OR
(aligner) OR (clear aligner) OR (invisalign) OR (vacuum-formed retainer) OR (vacuum formed
retainer)) AND ((BPA) OR (BPA release) OR (bisphenol A) OR (bisphenol-A) OR (bisphenol-A release)




((essix) OR (vacuum formed aligner) OR (vacuum-formed aligner) OR (thermoplastic aligner) OR
(aligner) OR (clear aligner) OR (invisalign) OR (vacuum-formed retainer) OR (vacuum formed
retainer)) AND ((BPA) OR (BPA release) OR (bisphenol A) OR (bisphenol-A) OR (bisphenol-A release)
OR (bisphenol A release) OR (monomer) OR (monomer release) OR (cytotoxicity) OR (estrogenicity))
6.
Open Grey −
(orthodontic aligner) AND (bisphenol) 0
(orthodontic retainer) AND (bisphenol) 0
7.
ClinicalTrials.gov (www.clinicaltrials.gov) −
(orthodontic aligner) AND (bisphenol) 0
(orthodontic retainer) AND (bisphenol) 0
8.
National Research Register (ISRCTN: www.controlled-trials.com) −
(orthodontic aligner) AND (bisphenol) 0
(orthodontic retainer) AND (bisphenol) 0
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